New risk categories for blood clots in the lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a blood clot in your lungs (pulmonary embolism) using a special CT scan within the last 24 hours.
- You are willing to be contacted for 30 days after you leave the emergency department.
- You agree to take part in the study.
- You are not pregnant.
- You have not had a blood clot in your lungs within the last 3 months.
- You do not have a long-term condition called chronic thromboembolic pulmonary hypertension (CTEPH).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.
This trial tests whether patients with a pulmonary embolism (a blood clot in the lungs) can be safely treated at home instead of being hospitalized, when they have some signs of heart strain but are not severely ill. Participants will be randomly assigned to either home treatment or hospital care to compare safety and recovery.
This study looks at people with interstitial lung disease (a lung scarring condition) who have new or worsening symptoms that might be caused by a blood clot in the lungs (pulmonary embolism). Doctors want to find better ways to predict which patients actually have a clot, which could lead to earlier and more accurate treatment.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
This study looks at how well certain scores, blood tests, and CT scan findings predict the severity of a pulmonary embolism (blood clot in the lungs). By joining, you may help doctors better understand and treat this condition.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.